Clinical Trials Logo

Insomnia clinical trials

View clinical trials related to Insomnia.

Filter by:

NCT ID: NCT02773693 Active, not recruiting - Insomnia Clinical Trials

Treatment of Comorbid Sleep Disorders and Post Traumatic Stress Disorder (PTSD)

Start date: August 2016
Phase: N/A
Study type: Interventional

The primary objective of the current study is to determine if providing cognitive-behavioral therapy of Insomnia and nightmares (CBTin) and Cognitive Processing Therapy of PTSD (CPT) results in greater PTSD and sleep symptom reduction than CPT only. A secondary objective is to determine if the sequencing of CBTl&N before or after CPT results in differential effects on PTSD and sleep symptom reduction.

NCT ID: NCT02756390 Completed - Insomnia Clinical Trials

CBTI-CS: A Novel Cognitive-Behavioral Treatment for Insomnia in Cancer Survivors

Start date: December 2015
Phase: N/A
Study type: Interventional

This research study is evaluating the effectiveness of a 3-session behavioral intervention for insomnia in cancer survivors. This is a behavioral intervention study, and no medications are involved.

NCT ID: NCT02747979 Completed - Insomnia Clinical Trials

The Effect and Safety of Hemodialysis and Hemoperfusion on Severe Renal Osteopathy and Itching in Uremia Patients

Start date: April 2009
Phase: Phase 2/Phase 3
Study type: Interventional

A prospective, randomized, controlled open clinic trial to evaluate the effect and safety of combination of conventional hemodialysis(HD) and hemoperfusion(HP) on middle molecules removal and complications improvement in long-term maintenance hemodialysis (MHD) patients. There are two phases of study for each subject. Phase 1 (screening phase). During this phase, each potential subject will be evaluated to determine if he/she is eligible for the study. Phase 2 (intervention phase). Each subject will be randomly allocated to HD+HP(HA130 once per week) group ,HD+HP(HA330 once per week) group and HD group. The follow-up duration was 3 months.

NCT ID: NCT02743338 Completed - Insomnia Clinical Trials

CompRest - a Comparison Between Sleep Compression and Sleep Restriction for Treating Insomnia

CompRest
Start date: July 2016
Phase: N/A
Study type: Interventional

This study includes two consecutive sub-trials. Cognitive Behavioral Therapy (CBT) is treatment of choice for Insomnia. One of the most important treatment Components in CBT for insomnia (CBT-i) is Sleep Restriction (SR), but lately, adverse effects related to SR have been reported. A treatment method with similarities to SR is Sleep Compression (SC). SC is not as well studied as SR, but appears to have similar effects to SR but without the adverse effects. The first sub-trial thus aims at directly comparing SR and SC. The second sub-trial aims at evaluating any additional effects of CBT-i components given as an add-on treatment to a randomized selection of half participants in each original treatment arm.

NCT ID: NCT02741336 Completed - Insomnia Clinical Trials

Electrophysiologic Changes in Blacks Treated With CBT for Insomnia

Start date: November 2015
Phase: N/A
Study type: Interventional

Insomnia is a highly prevalent, often debilitating, and economically burdensome condition. Reviews of the literature indicate that there are ethnic differences in sleep behavior, with African Americans objectively and subjectively reporting more disordered sleep than Caucasian Americans.Chronic insomnia can have a significant impact on mental and physical health outcomes and has been associated with impaired cognitive performance, particularly, in areas of speed, attention, working memory, and executive function. In order to understand the brain mechanisms in sleep disorder both during resting state as well as during cognitive processing, the investigators will assess resting state EEG (during eyes-closed and eyes-open conditions) as well as ERP tasks for assessing decision-making and reward processing. The primary objective of the study is to evaluate the effect of a tailored, telephone-delivered cognitive behavioral intervention, versus a self- monitoring control condition, on symptoms of insomnia and its neurodynamic correlates. Hypotheses: Among Blacks subjectively reporting symptoms of insomnia, those randomized to the tailored, telephone-delivered CBT-I, compared with those randomized to the self-monitoring control group, will have: Hyp. 1: Greater reduction in symptoms of insomnia as measured by the Pittsburgh Sleep Quality Index. Hyp. 2: Greater neurophysiologic improvement (ERP, ERO) in the intervention condition in response to laboratory paradigms Hyp 3: Greater improvement in psychosocial functioning including reduction in depression and increase in quality of life.

NCT ID: NCT02735954 Active, not recruiting - COPD Clinical Trials

Colorado Marijuana Users Health Cohort

Start date: September 2014
Phase:
Study type: Observational

In Colorado, marijuana is currently used for both recreational and medicinal purposes.To learn more about the positive and negative long term medical effects of marijuana use. Information obtained during this study may identify new markers that influence the development of lung diseases such as COPD. The Investigators are also interested in learning more about the effects of marijuana use for insomnia and how it may or may not affect sleep.

NCT ID: NCT02729714 Completed - Insomnia Clinical Trials

A Pilot Study of Suvorexant for Insomnia in Parkinson Disease

Start date: April 2016
Phase: Phase 4
Study type: Interventional

The purpose of this study is to see if the study drug, suvorexant, is safe and effective in treating symptoms of insomnia in people with Parkinson's Disease. It is anticipated that a total of 20 subjects, 30 to 80 years of age, with Parkinson's Disease and symptoms of insomnia will participate in the study at this site

NCT ID: NCT02721329 Completed - Clinical trials for Obstructive Sleep Apnea

Evaluation of APAP With SensAwake in OSA and Insomnia Patients

Start date: June 2016
Phase: N/A
Study type: Interventional

The hypothesis is that APAP with SensAwake improves wake-after sleep onset compared to APAP without SensAwake in a patient population with Obstructive Sleep Apnea Syndrome (OSAS) and Insomnia.

NCT ID: NCT02720458 Completed - Insomnia Clinical Trials

Self Help Program for Hypnotics Withdrawal in Insomniac Patients

PROPERSOM
Start date: October 4, 2016
Phase: N/A
Study type: Interventional

Persistent insomnia has a high prevalence in French general population affecting between 15.8 % and 19 % of adults. In France, the disease is mainly managed by general practitioners (GP) who usually proposed intermediate half-life benzodiazepines and Z-drugs in first-line treatment. French Health authorities recommend restricting the consumption of both hypnotics to no more than 4 weeks, considering their potential adverse effects (memory impairment, altered sleep physiology, motor-vehicle crash), and the risk of tolerance and dependence. However, it appears that a majority of patients become chronic users. Therefore, discontinuation of benzodiazepines/Z-drugs is recommended, but it may appear as a challenge due to withdrawal symptoms and psychological factors (anticipatory anxiety, fear of rebound insomnia). Numerous studies have shown that programs based on Cognitive-Behavioural Therapy (CBT) principles improve sleep and daily life quality leading to hypnotic taper and maintain of hypnotic abstinence in insomniac patients. Cognitive-Behavioural Therapy (CBT) is based on 4 components: sleep restriction, stimulus control, cognitive therapy and sleep hygiene education. This therapy is dependent on a therapeutic alliance between practitioner and patient. Unfortunately, there are an insufficient number of trained CBT experts especially in France. The implementation of an internet-delivered self-help program based on time-in-bed restriction and stimulus control may be an issue within the context of general practice. Online programs based on CBT principles have been proved to be effective in improving the sleep and daytime functioning in this population, but the studies were realized in small patients groups. Investigators hypothesis is that a simple and internet-delivered short-term program based on sleep restriction therapy and stimulus control (following to a GP consultation) may facilitate hypnotics discontinuation (benzodiazepines/Z-drugs) in patient with insomnia disorder still reporting sleep complaints in comparison with a tapering alone (no access to the self-help program).

NCT ID: NCT02717169 Recruiting - Insomnia Clinical Trials

Promoting Health Knowledge Among University Students

Start date: March 2016
Phase: N/A
Study type: Interventional

Background: The interactions between human beings and wearable technology like activity trackers equipped with biometric sensors can be linked to health related new learning concepts/instructional methods supporting deep knowledge acquisition, situated, self-regulated and active learning. This personalized, long term interactions where specific information is pushed to the learner contributes to deepen the personal understanding related to the concept of and knowledge about health and has an impact on long term health action process. Design and methods: In order to understand the behavioural change process, a multiple case study including 35 higher education students in Hong Kong from an undergraduate course, BSc Exercise and Health is currently conducted. Each student uses a wearable device (activity tracker) over a period of five months, reflects weekly on emerging personal data, documents their thinking and action in the ePortfolio, and engages in an online forum. The participants enter their experiences with the biometric data, lifestyle adaptations (e.g. more steps), special situations (e.g. hike, heart rate changes during activity) and how these experiences lead to specific searches and actions on the web and/or in their real social network. The ePortfolio will allow the students to critically reflect on their progress and for the researchers to intervene at any time on the issues related to the participants' postings. EHealth literacy is used as indicator for the health action process of the participants. Evidence regarding change in eHealth at the beginning and end of the intervention will be collected with a standard questionnaire detecting eHealth their literacy scale. Scope: By reflecting on the information from their personal activity tracker and documenting it in their own ePortfolio, the students will continuously learn to analyse, search and critically assess health related personal and available digital information, organize it, present and discuss it with peers/tutor. This in turn will enhance critical thinking, raise questions about health related topics, stimulate further inquiry deepen their knowledge about personal health, inducing a healthier lifestyle.